The helical domains of the stem region of dengue virus envelope protein are involved in both virus assembly and entry

Journal of Virology

Volumn 85, Issue 10, 2011, Pages 5159-5171

  Lin, Su Ru ^a   Zou, Gang ^c   Hsieh, Szu Chia ^a,b   Qing, Min ^c   Tsai, Wen Yang ^b   Shi, Pei Yong ^c   Wang, Wei Kung ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b UNIVERSITY OF HAWAII   (United States)

^c NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ENVELOPE PROTEIN; PROLINE;

ALPHA HELIX; AMINO ACID SUBSTITUTION; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DENGUE VIRUS; DENGUE VIRUS 2; DENGUE VIRUS 4; DIMERIZATION; ENDOPLASMIC RETICULUM; MEMBRANE BINDING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; REPLICON; SEQUENCE ANALYSIS; VIRION; VIRUS ASSEMBLY; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS LIKE AGENT; VIRUS MUTATION; VIRUS REPLICATION;

AMINO ACID SUBSTITUTION; DENGUE VIRUS; IMMUNOPRECIPITATION; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; RADIOIMMUNOASSAY; VIRAL ENVELOPE PROTEINS; VIROSOMES; VIRUS ASSEMBLY; VIRUS INTERNALIZATION;

DENGUE VIRUS;

EID: 79955417646     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02099-10     Document Type: Article

References (61)

1. Allison, S. L., K. Stiasny, K. Stadler, C. W. Mandl, and F. X. Heinz. 1999. Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J. Virol. 73:5605-5612.
2. Bray, M., R. Men, I. Tokimatsu, and C. J. Lai. 1998. Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence. J. Virol. 72:1647-1651.
3. Bressanelli, S., et al. 2004. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J. 23:728-738.
4. Chang, G. J., et al. 2003. Enhancing biosynthesis and secretion of premem-brane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus. Virology 306:170-180.
5. Chen, S. S., S. F. Lee, and C. T. Wang. 2001. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41. J. Virol. 75:9925-9938.
6. Davis, B. S., et al. 2001. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 75:4040-4047.
7. Ferlenghi, I., et al. 2001. Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol. Cell 7:593-602.
8. Gehrke, R., et al. 2003. Incorporation of tick-borne encephalitis virus repli-cons into virus-like particles by a packaging cell line. J. Virol. 77:8924-8933.
9. Green, S., and A. Rothman. 2006. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr. Opin. Infect. Dis. 19:429-436.
10. Gubler, D. J. 2002. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 10:100-103.
11. Guirakhoo, F., A. R. Hunt, J. G. Lewis, and J. T. Roehrig. 1993. Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology 194:219-223.
12. Guzman, M. G., and G. Kouri. 2002. Dengue: an update. Lancet Infect. Dis. 2:33-42.
13. Halstead, S. B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481.
14. Hrobowski, Y. M., R. F. Garry, and S. F. Michael. 2005. Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol. J. 2:49.
15. Hsieh, S. C, I. J. Liu, C. C. King, G. J. Chang, and W. K. Wang. 2008. A strong endoplasmic reticulum retention signal in the stem-anchor region of envelope glycoprotein of dengue virus type 2 affects the production of virus-like particles. Virology 374:338-350.
16. Hu, H. P., S. C. Hsieh, C. C. King, and W. K. Wang. 2007. Characterization of retrovirus-based reporter viruses pseudotyped with the precursor membrane and envelope glycoproteins of four serotypes of dengue viruses. Virology 368:376-387.
17. Hunt, A. R., C. B. Cropp, and G. J. Chang. 2001. A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen. J. Virol. Methods 97:133-149.
18. Jones, C. T., C. G. Patkar, and R. J. Kuhn. 2005. Construction and applications of yellow fever virus replicons. Virology 331:247-259.
19. Kaufmann, B., et al. 2009. Capturing a flavivirus pre-fusion intermediate. PLoS Pathog. 5:e1000672.
20. Keelapang, P., et al. 2004. Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses. J. Virol. 78:2367-2381.
21. Khromykh, A. A., A. N. Varnavski, and E. G. Westaway. 1998. Encapsidation of the flavivirus Kunjin replicon RNA by using a complementation system providing Kunjin virus structural proteins in trans. J. Virol. 72:5967-5977.
22. Kielian, M., and F. A. Rey. 2006. Virus membrane-fusion proteins: more than one way to make a hairpin. Nat. Rev. Microbiol. 4:67-76.
23. Konishi, E., and A. Fujii. 2002. Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine. Vaccine 20:1058-1067.
24. Kroeger, M. A., and P. C. McMinn. 2002. Murray Valley encephalitis virus recombinant subviral particles protect mice from lethal challenge with virulent wild-type virus. Arch. Virol. 147:1155-1172.
25. Liao, M., and M. Kielian. 2005. Domain III from class II fusion proteins function as a dominant-negative inhibitor of virus membrane fusion. J. Cell Biol. 171:111-120.
26. Lindenbach, B. D., H. J. Thiel, and C. M. Rice. 2007. Flaviviridae: the viruses and their replication, p. 1101-1152. In D. M. Knipe and P. M. Howley (ed.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, PA.
27. Lo, M. K., M. Tilgner, K. A. Bernard, and P. Y. Shi. 2003. Functional analysis of mosquito-borne flavivirus conserved sequence elements within 3' untranslated region of West Nile virus by use of a reporting replicon that differentiates between viral translation and RNA replication. J. Virol. 77:10004-10014.
28. Lorenz, I. C, et al. 2003. Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. J. Virol. 77:4370-4382.
29. Mackenzie, J. M., and E. G. Westaway. 2001. Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J. Virol. 75:10787-10799.
30. Martin, J. E., et al. 2007. A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial. J. Infect. Dis. 196:1732-1740.
31. Modis, Y., S. Ogata, D. Clements, and S. C. Harrison. 2003. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 100:6986-6991.
32. Modis, Y., S. Ogata, D. Clements, and S. C. Harrison. 2004. Structure of the dengue virus envelope protein after membrane fusion. Nature 427:313-319.
33. Modis, Y., S. Ogata, D. Clements, and S. C. Harrison. 2005. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J. Virol. 79:1223-1231.
34. Mukhopadhyay, S., R. J. Kuhn, and M. G. Rossmann. 2005. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 3:13-22.
35. Murray, J. M., J. G. Aaskov, and P. J. Wright. 1993. Processing of the dengue virus type 2 proteins prM and C-prM. J. Gen. Virol. 74(Pt 2):175-182.
36. Op De Beeck, A., et al. 2003. Role of the transmembrane domains of prM and E proteins in the formation of yellow fever virus envelope. J. Virol. 77:813-820.
37. Orlinger, K. K., V. M. Hoenninger, R. M. Kofler, and C. W. Mandl. 2006. Construction and mutagenesis of an artificial bicistronic tick-borne encephalitis virus genome reveals an essential function of the second transmem-brane region of protein E in flavivirus assembly. J. Virol. 80:12197-12208.
38. Pierson, T. C., et al. 2006. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346: 53-65.
39. Poh, M. K., et al. 2009. A small molecule fusion inhibitor of dengue virus. Antiviral Res. 84:260-266.
40. Puig-Basagoiti, F., et al. 2005. High-throughput assays using luciferase-expressing replicon, virus-like particle, and full-length virus for West Nile virus drug discovery. Antimicrob. Agents Chemother. 49:4980-4988.
41. Purdy, D. E., A. J. Noga, and G. J. Chang. 2004. Noninfectious recombinant antigen for detection of St. Louis encephalitis virus-specific antibodies in serum by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 42:4709- 4717.
42. Purdy, D. E., and G. J. Chang. 2005. Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein. Virology 333:239- 250.
43. Qing, M., W. Liu, Z. Yuan, F. Gu, and P. Y. Shi. 2010. A high-throughput assay using dengue-1 virus-like particles for drug discovery. Antiviral Res. 86:163-171.
44. Randolph, V. B., and V. Stollar. 1990. Low pH-induced cell fusion in flavi-virus-infected Aedes albopictus cell cultures. J. Gen. Virol. 71:1845-1850.
45. Randolph, V. B., G. Winkler, and V. Stollar. 1990. Acidotropic amines inhibit proteolytic processing of flavivirus prM protein. Virology 174:450-458.
46. Russell, P. K., W. E. Brandt, and J. M. Dalrymple. 1980. Chemical and antigenic structure of flaviviruses, p. 503-529. In R. W. Schlesinger (ed.), The togaviruses. Academic Press, New York, NY.
47. Schalich, J., et al. 1996. Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J. Virol. 70:4549-4557.
48. Schmidt, A. G., P. L. Yang, and S. C. Harrison. 2010. Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog. 6:e1000851.
49. Scholle, F., Y. A. Girard, Q. Zhao, S. Higgs, and P. W. Mason. 2004. Trans-packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors. J. Virol. 78:11605-11614.
50. Shi, P. Y., M. Tilgner, M. K. Lo, K. A. Kent, and K. A. Bernard. 2002. Infectious cDNA clone of the epidemic West Nile virus from New York City. J. Virol. 76:5847-5856.
51. Shin, J., R. L. Dunbrack, Jr., S. Lee, and J. L. Strominger. 1991. Signals for retention of transmembrane proteins in the endoplasmic reticulum studied with CD4 truncation mutants. Proc. Natl. Acad. Sci. U. S. A. 88:1918-1922.
52. Stadler, K., S. L. Allison, J. Schalich, and F. X. Heinz. 1997. Proteolytic activation of tick-borne encephalitis virus by furin. J. Virol. 71:8475-8481.
53. Stiasny, K., S. L. Allison, A. Marchler-Bauer, C. Kunz, and F. X. Heinz. 1996. Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus. J. Virol. 70:8142- 8147.
54. Wang, S., R. He, and R. Anderson. 1999. PrM- and cell-binding domains of the dengue virus E protein. J. Virol. 73:2547-2551.
55. Wang, W. K., et al. 2006. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin. Infect. Dis. 43:1023-1030.
56. Welsch, S., et al. 2009. Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe 5:365- 375.
57. World Health Organization. 2009. Dengue and dengue hemorrhagic fever. Fact sheet no. 117. World Health Organization, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs117/en.
58. Xu, Z., V. Bruss, and T. S. Yen. 1997. Formation of intracellular particles by hepatitis B virus large surface protein. J. Virol. 71:5487-5494.
59. Yu, I. M., et al. 2008. Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319:1834-1837.
60. Zhang, W., et al. 2003. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat. Struct. Biol. 10:907-912.
61. Zhang, Y., et al. 2004. Conformational changes of the flavivirus E glycoprotein. Structure 12:1607-1618.